CLINICAL HIGHLIGHT: Optimizing Care for the 51%: New Market Opportunities
Tuesday, May 2nd, 2017, 3:40 pm - 4:30 pm
Location: Boston Scientific Ballroom
Introduction: Cathy Minehan, Chair, MGH Corporation
Address implications of gender as a key biological factor for personalized medicine. Stroke is likely to be the first cardiovascular event, tied to AF and secondarily to hypertension. Opportunities for medication utilization and optimization in context of, manifestation of disease and understanding the biology, complications, strategies to collect relevant clinical evidence, and treatment response.